.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Boehringer Ingelheim
Express Scripts
McKesson
Teva
Fish and Richardson
Healthtrust
Merck
Novartis
Moodys
Cantor Fitzgerald

Generated: September 23, 2017

DrugPatentWatch Database Preview

LYMPHOSEEK KIT Drug Profile

« Back to Dashboard

Which patents cover Lymphoseek Kit, and when can generic versions of Lymphoseek Kit launch?

Lymphoseek Kit is a drug marketed by Cardinal Hlth 414 and is included in one NDA. There are two patents protecting this drug.

This drug has twenty-three patent family members in eleven countries.

The generic ingredient in LYMPHOSEEK KIT is technetium tc-99m tilmanocept. There are four drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the technetium tc-99m tilmanocept profile page.

Summary for Tradename: LYMPHOSEEK KIT

Patents:2
Applicants:1
NDAs:1
Suppliers / Packagers: see list2
Clinical Trials: see list447
Drug Prices:see details
DailyMed Link:LYMPHOSEEK KIT at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Cardinal Hlth 414
LYMPHOSEEK KIT
technetium tc-99m tilmanocept
INJECTABLE;INJECTION202207-001Mar 13, 2013RXYesYes► Subscribe► SubscribeY ► Subscribe
Cardinal Hlth 414
LYMPHOSEEK KIT
technetium tc-99m tilmanocept
INJECTABLE;INJECTION202207-001Mar 13, 2013RXYesYes► Subscribe► Subscribe► Subscribe
Cardinal Hlth 414
LYMPHOSEEK KIT
technetium tc-99m tilmanocept
INJECTABLE;INJECTION202207-001Mar 13, 2013RXYesYes► Subscribe► SubscribeYY ► Subscribe
Cardinal Hlth 414
LYMPHOSEEK KIT
technetium tc-99m tilmanocept
INJECTABLE;INJECTION202207-001Mar 13, 2013RXYesYes► Subscribe► Subscribe► Subscribe
Cardinal Hlth 414
LYMPHOSEEK KIT
technetium tc-99m tilmanocept
INJECTABLE;INJECTION202207-001Mar 13, 2013RXYesYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Non-Orange Book Patents for Tradename: LYMPHOSEEK KIT

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
8,545,808Compositions for radiolabeling diethylenetriaminepentaacetic acid (DTPA)-dextran► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Tradename: LYMPHOSEEK KIT

Country Document Number Estimated Expiration
Japan5743905► Subscribe
Japan2015164933► Subscribe
Japan2007332380► Subscribe
China102301429► Subscribe
South Korea20110115148► Subscribe
Spain2228536► Subscribe
European Patent Office1178838► Subscribe
Germany60014359► Subscribe
Australia2010208624► Subscribe
Japan6040276► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Supplementary Protection Certificates for Tradename: LYMPHOSEEK KIT

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
C0033France► SubscribePRODUCT NAME: TILMANOCEPT; REGISTRATION NO/DATE: EU/1/14/955 20141121
90025-1Sweden► SubscribePRODUCT NAME: TILMANOCEPT; REG. NO/DATE: EU/1/14/955 20141120
0736Netherlands► SubscribePRODUCT NAME: TILMANOCEPT, DESGEWENST GELABELD MET TECHNETIUM TC 99M; REGISTRATION NO/DATE: EU/1/14/955 20141119
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

McKesson
Johnson and Johnson
AstraZeneca
Cipla
Novartis
Chubb
Moodys
Healthtrust
Baxter
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot